SCHEMBL6233946

SCHEMBL6233946

OCc1ccc(-c2cnc3nc(-c4cccs4)c(-c4cccs4)nc3c2)s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.50
RPS6KB2 Q9UBS0 10/20 0.44
CYP2A6 P11509 1/20 0.42
HIF1A Q16665 3/20 0.37
EPAS1 Q99814 2/20 0.37
PDGFRB P09619 1/20 0.37
PDGFRA P16234 1/20 0.37
SRPK1 Q96SB4 1/20 0.37
LTA4H P09960 1/20 0.36
GRIN1 Q05586 1/20 0.35
GRIN2B Q13224 1/20 0.35
DHFR P00374 1/20 0.35
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6235329 0.88 RPS6KB2 (0.42) DPP4RPS6KB2HIF1APDGFRBPDGFRA
SCHEMBL6236374 0.84 RPS6KB2 (0.54) RPS6KB2CYP2A6HIF1APDGFRBPDGFRA
SCHEMBL6257438 0.81 USP2 (0.44) RPS6KB2HIF1AMEN1USP2ALDH1A1
SCHEMBL6234678 0.79 DPP4 (0.50) DPP4RPS6KB2CYP2A6HIF1APDGFRB
SCHEMBL6234523 0.77 CYP1A2 (0.42) RPS6KB2HIF1AMEN1USP2ALDH1A1
SCHEMBL6237798 0.77 RPS6KB2 (0.52) RPS6KB2PDGFRBPDGFRASRPK1DHFR
SCHEMBL6237105 0.76 RPS6KB2 (0.49) RPS6KB2CYP2A6HIF1APDGFRBPDGFRA
SCHEMBL6240193 0.75 MAPT (0.51) RPS6KB2SRPK1CYP3A4CYP2C9CLK4
SCHEMBL6236517 0.73 CYP2A6 (0.55) RPS6KB2CYP2A6PDGFRBPDGFRAALDH1A1
SCHEMBL6239563 0.72 RPS6KB2 (0.53) RPS6KB2HIF1ASRPK1DHFRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005007099-A2 PKB INHIBITORS AS ANTI-TUMOR AGENTS IMCLONE SYSTEMS INCORPORATED (US) 2005-01-27 WO disclosed